Gene · 6311
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice. | Environ Int | 2021 | 33221593 | PubTator, text mining | PubMed |
| Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS. | Neurol Neuroimmunol Neuroinflamm | 2021 | 33214142 | PubTator, text mining | PubMed |
| The X-linked intellectual disability gene product and E3 ubiquitin ligase KLHL15 degrades doublecortin proteins to constrain neuronal dendritogenesis. | J Biol Chem | 2021 | 33199366 | PubTator, text mining | PubMed |
| The Use of New Mobile and Gaming Technologies for the Assessment and Rehabilitation of People with Ataxia: a Systematic Review and Meta-analysis. | Cerebellum | 2021 | 33190189 | PubTator, text mining | PubMed |
| Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies. | Crit Rev Biochem Mol Biol | 2021 | 33172304 | PubTator, text mining | PubMed |
| Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project. | Mov Disord | 2021 | 33159825 | PubTator, text mining | PubMed |
| Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis. | J Neurochem | 2021 | 33155274 | PubTator, text mining | PubMed |
| New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia. | J Mov Disord | 2021 | 33121221 | PubTator, text mining | PubMed |
| Contribution of the Cerebellum and the Basal Ganglia to Language Production: Speech, Word Fluency, and Sentence Construction-Evidence from Pathology. | Cerebellum | 2021 | 33120434 | PubTator, text mining | PubMed |
| DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder. | J Neurol | 2021 | 33106889 | PubTator, text mining | PubMed |
| Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms. | Ann Rheum Dis | 2021 | 33106285 | PubTator, text mining | PubMed |
| Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1. | Cerebellum | 2021 | 33063293 | PubTator, text mining | PubMed |
| A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS. | Mov Disord | 2021 | 33058338 | PubTator, text mining | PubMed |
| Antisense Drugs Make Sense for Neurological Diseases. | Annu Rev Pharmacol Toxicol | 2021 | 33035446 | PubTator, text mining | PubMed |
| In vivo microstructural white matter changes in early spinocerebellar ataxia 2. | Acta Neurol Scand | 2021 | 33029780 | PubTator, text mining | PubMed |
| Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data. | Environ Res | 2021 | 33027627 | PubTator, text mining | PubMed |
| Orphan Peripheral Neuropathies. | J Neuromuscul Dis | 2021 | 32986679 | PubTator, text mining | PubMed |
| Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis. | J Mol Cell Biol | 2021 | 32976566 | PubTator, text mining | PubMed |
| Long non-coding RNAs in motor neuron development and disease. | J Neurochem | 2021 | 32970857 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6311/papers?page=54